SHH · 603567.SS · CNY
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 07:00 AM UTC. Cached market data; not a live quote.
One-year closing-price history · CNY. Historical prices are not a forecast.
Heilongjiang ZBD Pharmaceutical Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 61.61% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Heilongjiang ZBD Pharmaceutical Co., Ltd.’s forward annual dividend is CN¥0.15 per share, paid annual. The forward yield is 3.28% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Heilongjiang ZBD Pharmaceutical Co., Ltd.’s next earnings report is currently expected on Oct 31, 2026. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow Heilongjiang ZBD Pharmaceutical Co., Ltd.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Heilongjiang ZBD Pharmaceutical Co., Ltd. is a Chinese pharmaceutical firm dedicated to the entire lifecycle of Traditional Chinese Medicine (TCM), from research and development to manufacturing and sales, exclusively within China. Its extensive product portfolio addresses a wide spectrum of health concerns, including conditions related to cardiovascular and cerebrovascular health, respiratory ailments, orthopedic issues, oncology, digestive disorders, anti-infective treatments, neuropsychiatric conditions, and genitourinary problems, among others. Established in 1996, the company maintains its headquarters in Hulin, China.
Latest available per-share figures in CNY. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 08:27 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
| CN¥543.31M |
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
CN¥3.07-CN¥0.01 (-0.32%)
Tianjin Chase Sun Pharmaceutical Co., Ltd. Class A’s quoted price sits in the lower half of its reported 52-week range, 23.06% below the high.
CN¥5.54-CN¥0.26 (-4.48%)
Zhejiang Hisoar Pharmaceutical Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 39.05% below the high.
CN¥4.37+CN¥0.12 (+2.82%)
Huapont Life Sciences Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 28.13% below the high.
CN¥16.27+CN¥0.06 (+0.37%)
Tianjin Ringpu Bio-Technology Co.,Ltd.’s quoted price sits in the lower half of its reported 52-week range, 25.4% below the high.
CN¥6.05+CN¥0.31 (+5.4%)
Changzhou Qianhong Biopharma CO.,LTD’s quoted price sits in the lower half of its reported 52-week range, 35.91% below the high.
CN¥4.55+CN¥0.01 (+0.22%)
North China Pharmaceutical Company Ltd.’s quoted price sits in the lower half of its reported 52-week range, 34.06% below the high.
CN¥2.14-CN¥0.06 (-2.73%)
Guangxi Wuzhou Zhongheng Group Co.,Ltd’s quoted price sits in the lower half of its reported 52-week range, 30.97% below the high.
CN¥12.14+CN¥0.04 (+0.33%)
Chongqing Taiji Industry(Group) Co.,Ltd’s quoted price sits in the lower half of its reported 52-week range, 42.52% below the high.
